Boston Scientific Corporation (BSX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
43.40+0.15 (+0.35%)
At close: 4:00PM EDT
43.56 +0.16 (+0.37%)
After hours: 05:15PM EDT
After hours: 05:15PM EDT
| Previous close | 43.25 |
| Open | 43.58 |
| Bid | 43.40 x 1800 |
| Ask | 43.72 x 1200 |
| Day's range | 43.05 - 43.68 |
| 52-week range | 32.99 - 46.29 |
| Volume | 5,502,445 |
| Avg. volume | 6,425,675 |
| Market cap | 61.667B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 307.80 |
| EPS (TTM) | 0.14 |
| Earnings date | 26 Oct 2021 - 01 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 50.87 |
- Zacks
Boston Scientific (BSX) Inks New Deal to Buy Baylis Medical
The Baylis Medical buyout is expected to expand Boston Scientific's (BSX) electrophysiology and structural heart product offerings.
- Zacks
Boston Scientific's (BSX) Ranger DCB Trial Outcome Favorable
Boston Scientific's (BSX) Ranger DCB two-year data demonstrates a constant, high rate of efficacy in patients with more complex lesion subtypes.
- Zacks
Boston Scientific (BSX) Reports Data Backing Eluvia Stent
The positive data demonstrated the superiority of Boston Scientific's (BSX) Eluvia stent compared to bare metal stents in treating patients with peripheral artery disease.
© 2021 Verizon Media. All rights reserved.
